Ranbaxy Laboratories Ltd.
Division of Sun Pharmaceutical Industries Ltd.
www.ranbaxy.com
Latest From Ranbaxy Laboratories Ltd.
Asia Trial Setbacks, Asset Returns Symptomatic Of Industry Challenges?
While deal-making in the Asian pharma space shows no signs of slowing down, the past few months have been marked by a series of high-profile cases involving the return of rights by licensees or setbacks in clinical trials. Scrip's regional team looks at some of the factors at work.
US FDA's Rush Following Novartis' Delay Suggests Strong Displeasure With Handling Of Zolgensma Data Manipulation
Early release of inspection findings is unusual, signaling likelihood that Novartis will face tough scrutiny of its actions, and perhaps stiff fines because of the fraud.
Novartis' Zolgensma Had Manipulated Data In Application, US FDA Says
Gene therapy should remain on the market, FDA says, but Novartis could face civil or criminal penalties. Firm knew of problems before approval.
IPA's Jain On The Journey So Far And Fires To Douse
Sudarshan Jain, the new secretary general of the Indian Pharmaceutical Alliance and ex-Abbott managing director, wears many hats, including that of a senior advisor with a private equity advisory firm. He recounts having “survived in different cultures” in his career and outlines the priorities in his new role, amid continuing questions around generic quality.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
- Services
- Therapeutic Areas
- Cardiovascular
- Dermatology
- Gastrointestinal
- Gynecological, Urological
- Infectious & Viral Diseases
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
India
-
India
-
Asia
- Parent & Subsidiaries
- Sun Pharmaceutical Industries Ltd.
- Senior Management
-
Arun Sawhney, CEO & Managing Dir.
Indrajit Banerjee, Pres. & CFO
Sanjeev I Dani, EVP, Corp. & Bus. Dev.
Rajiv Gulati, Pres., Global Pharma Bus. - Contact Info
-
Ranbaxy Laboratories Ltd.
Phone: (91) 124 4135000
Plot 90, Sector 32
Gurgaon , 122001
India
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice